A large new analysis draws a surprising connection between cannabis use and brain structure in middle-aged and older adults, finding larger volumes in several regions and modestly better scores on certain cognitive tests, while researchers urge caution because the work is observational and limited by available data.
Researchers at the University of Colorado Anschutz Medical Campus tapped the UK Biobank and examined brain scans and cognitive tests from more than 26,000 people aged 40 to 77. That scope gives the study statistical weight and some fresh angles on long-term associations between cannabis and the aging brain. The dataset is rich but also constrained by how questions were originally asked.
The headline result: people who reported moderate lifetime cannabis use tended to show larger volumes in several brain regions. “Compared to individuals with no history of cannabis use, those who reported using cannabis showed larger volumes in several brain regions characterized by a high density of cannabinoid (CB1) receptors — regions involved in processes such as memory, information processing and emotion regulation,” lead study author Anika Guha, Ph.D., a researcher at the University of Colorado Anschutz Medical Campus, told Fox News Digital. Those anatomical differences aligned with better performance on tests of learning, processing speed and executive function for cannabis users in the sample.
That pattern contrasts with the bulk of past work, which has mostly documented short-term impairment during or immediately after use. “These findings suggest that the relationship between cannabis and the brain may differ across the lifespan, and that moderate use in mid-to-later adulthood may be associated with positive brain health outcomes,” Guha said. The implication is that timing and dose could matter a lot when we think about long-term effects.
Not every brain area looked better in users, though, and the results are not uniformly optimistic. The posterior cingulate, a region tied to self-reflection and memory, showed lower volume among heavier users in the dataset. Those mixed signals make the findings intriguing but far from definitive.
Outside experts urged careful interpretation and further study before anyone treats this as a green light. “Given the connection between cannabis use and larger brain volume, it is believed that it may help [older] individuals retain cognitive function that might otherwise naturally decline,” Chicago-based Matt Glowiak, Ph.D., chief addiction specialist with Recovered, told Fox News Digital. “This is a huge benefit, but one we need to explore a bit further, ahead of encouraging those who would otherwise not consider integrating cannabis into their healthcare regimen.”
Other commentators reminded readers that this paper sits apart from most prior evidence. “The preponderance of previous evidence does not line up with improved cognitive function from chronic cannabis use,” Siegel told Fox News Digital. “This study is an outlier, and though it cannot be ignored, it is not justification for use.” That caution matters when clinical advice and public perception can shift quickly around headline studies.
Methodological limits are front and center. “In particular, we have only a broad measure of how many times someone has used cannabis over their lifetime,” she said. “We do not have access to details about how they used cannabis, such as whether they smoked or used edibles, the type or potency of cannabis, or when in their life they used most heavily.” “Those details likely matter a great deal for understanding how cannabis affects the aging brain.”
Guha is careful about messaging. “The takeaway is not that people should start using more cannabis based on these findings alone,” she emphasized. “While cannabis may have potential benefits in some contexts, a substantial body of research also documents important risks, underscoring that cannabis is neither completely beneficial nor completely harmful.” That balanced stance recognizes potential upside without dismissing known downsides.
The investigators and outside clinicians agree on one practical point: more targeted research is needed. “As with any substance, individuals should consult with a healthcare provider before initiating use, particularly if they have a history of mental health concerns, as THC (the primary psychoactive component of cannabis) can exacerbate symptoms such as psychosis in vulnerable individuals,” she added. Clinical nuance, product details and personal vulnerability all influence outcomes.
Some specialists called the study promising but preliminary. Dr. Alex Dimitriu, who is double board-certified in psychiatry and sleep medicine, reiterated that this study is an “outlier,” as most previous research has shown “detrimental effects” from cannabis use. “Given the widespread use and legalization of cannabis, it would be great to know that it is net-positive for brain health — however, this feels too good to be true, and too early to claim,” he said. “I would advise proceeding with caution and moderation.” “What this cannabis study shows is that there may be conflicting information, which warrants more investigation.”
